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Abstract
Background: Achondroplasia is a well-defined and common bone dysplasia. Genotype- and phenotype-level
correlations have been found between the clinical symptoms of achondroplasia and achondroplasia-specific FGFR3
mutations.
Result: A 2-year-old boy with clinical features consistent with achondroplasia and Silver-Russell syndrome-like
symptoms was found to carry a mutation in the fibroblast growth factor receptor-3 (FGFR3) gene at c.1138G > A
(p.Gly380Arg) and a de novo 574 kb duplication at chromosome 7p12.1 that involved the entire growth-factor
receptor bound protein 10 (GRB10) gene. Using quantitative real-time PCR analysis, GRB10 was over-expressed, and,
using enzyme-linked immunosorbent assays for IGF1 and IGF-binding protein-3 (IGFBP3), we found that IGF1 and
IGFBP3 were low-expressed in this patient.
Conclusions: We demonstrate that a combination of uncommon, rare and exceptional molecular defects related to
the molecular bases of particular birth defects can be analyzed and diagnosed to potentially explain the observed
variability in the combination of molecular defects.
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Background
Achondroplasia (ACH, OMIM #100800) is the most
common non-lethal skeletal dysplasia. It is an autosomal-
dominant disorder with an incidence of approximately 5–
15 per 100,000 live births. Mutations in FGFR3 at
c.1138 G >A (p.Gly380Arg) are known to cause ACH, with
97 % of cases involving this mutation [8, 22]. Gain-of-
function mutations in FGFR3 have been shown to cause
both chondrodysplasias and craniosynostoses and to result
in impaired endochondral ossification [3].
While patients with maternal uniparental disomy of
chromosome 7 (mUPD7) that involves GRB10 are con-
sistently diagnosed with Silver–Russell syndrome (SRS,
OMIM #180860) [4, 7]. SRS is a rare congenital develop-
mental disorder that is characterized by severe intrauter-
ine and postnatal growth restriction, a triangular-shaped
face, and congenital malformations that include relative
macrocephaly, hemihypotrophy, and fifth-finger clino-
dactyly [24]. However, there is no conclusive evidence
regarding the pathogenic mechanism by which GRB10
(i.e., imprinting vs. dosage) contributes to the etiology of
SRS.
Currently, only 6 SRS patients have been shown to
carry GRB10 duplications. In 1999, Joyce et al. described
a mother and daughter who were both diagnosed with
SRS and who both carried a duplication at 7p12.1-p13,
which includes GRB10 and IGFBP1. The mother carried
a paternally derived duplication, and the daughter
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carried a maternally derived duplication [13]. The next
year, Monk et al. reported a de novo maternal duplica-
tion of 7p11.2-p13 in a patient with SRS [17]. Subse-
quently, two more individuals (A.C. and H.C.) with SRS
were reported to possess larger duplications at this same
locus: A.C. carried a maternally derived duplication, but
the parent of origin for H.C.’s duplication was not
known [16]. Recently, Eggermann reported a boy who
displayed heterogeneous growth patterns and carried a
de novo paternally derived duplication at 7p12.2 [6]. A
few additional cases have been reported to the Decipher
and ISCA databases (Fig. 4a, Table 1). All of these re-
ported duplications involved the GRB10 gene, which is
regarded as the most promising candidate gene at this
locus (Fig. 2). Because all of these duplications were
large (except Decipher case 289205, which had a partial
GRB10 gene duplication), it is possible that neighboring
genes, particularly genes such as IGFBP1 and IGFBP3,
could contribute to SRS, and the involvement of these
genes has not been completely ruled out in these cases.
As a result, the correlations between SRS genotypes and
phenotypes that are associated with duplications of
GRB10 remain incompletely understood.
Here, we report a patient who displayed prenatal onset
growth delay and ACH and carried a small de novo du-
plication at 7p12.1 that involved the GRB10 gene in
addition to a heterozygous point mutation at FGFR3.
We detected the smallest known duplication in a patient
who displayed one of the typical clinical features of SRS.
This duplication was restricted to the GRB10 gene at
7p12.1. This case provides direct evidence showing that
a GRB10 duplication is sufficient to cause the prenatal
onset growth delay phenotype in SRS and the combin-
ation of these two molecular defects may explain the so-
called variable expressivity dominant traits.
Methods
Clinical report
A 2-year-old Chinese boy was referred and admitted to
our hospital because of congenital malformations and
development delay over the previous month. He pre-
sented with a characteristically small triangular face with
a prominent forehead and low nasal bridge, micro-
gnathia and downturned corners of the mouth, and
sparse hair (Fig. 1). He could not walk but could sit with
support, and his language development was significantly
delayed. He had been previously diagnosed with global
developmental delay (date not provided), and he exhib-
ited short limbs and relative macrocephaly without com-
pensatory growth at 6 months of age.
A physical examination resulted in the following findings:
height, 66 cm (<1 rd percentile); weight, 7.5 kg (<1 rd per-
centile); head circumference, 52 cm (<3 rd percentile); and
BMI, 17.2 kg/m2, indicating a persistent failure to thrive. In
addition, the patient had trident hands and fifth finger clin-
odactyly. An X-ray of the hand showed stubby fingers,
metaphyseal enlargement, bilateral slight curvature of the
radius and ulna, and delayed bone age. A spine X-ray
showed mild scoliosis and kyphosis at the thoracic and
lumbar region (Fig. 2), which indicated achondroplasia. A
cerebral MRI showed a hypoplastic corpus callosum, en-
largement of the lateral ventricles and hydrocephalus
(Fig. 3). In addition, he exhibited muscular hypotonia and
sleep-related symptoms (e.g., snoring, mouth breathing, ob-
served apneas, and excessive sweating). An ophthalmo-
logical examination and neurometabolic investigation were
normal. Based on the above clinical phenotype, a diagnosis
of SRS-like symptoms and achondroplasia was suspected.
The patient was the fourth child of healthy unrelated
parents with a negative family history. His siblings were
all healthy. Fetal short limbs were noticed on the ultra-
sound examination at 8 months of pregnancy, indicating
intrauterine growth restriction (date not provided). He
was born by vaginal delivery at 38 weeks of gestation
after an uneventful pregnancy. His birth weight was
1900 g (<1st percentile), his length was 43 cm (<1st per-
centile) and his head circumference was 34 cm. His
Apgar scores were all 9 s. Feeding difficulty was noted
during the first two months after birth.
Karyotyping and chromosomal microarray analysis
A standard chromosome analysis at 550-band resolution
was performed using cultured peripheral blood from the
patient according to standard procedures.
A chromosomal microarray analysis (CMA) of the pa-
tient and his parents was performed using an Affymetrix
Cytoscan HD Array (Affymetrix, Santa Clara, CA, USA).
Genomic DNA was extracted from peripheral blood
using a commercial kit (Qiagen). The labeling and
hybridization procedures were performed according to
the manufacturer’s instructions. The raw CMA data
were analyzed using Affymetrix Chromosome Analysis
Suite software. The microarray data for the family trio
were then processed using the standard protocols pro-
vided by the manufacturer to perform a basic analysis
using Chromosome Analysis Suite software (NetAffx
33.1, Affymetrix, USA).
Confirmation of GRB10 duplication
The GRB10 copy number was further confirmed using
quantitative real-time PCR analysis. The primer se-
quences that were used and their descriptions are in-
cluded in Additional file 1: Table S1.
GRB10 expression level
GRB10 expression levels were detected in blood samples
using quantitative real-time PCR analysis. Total RNA
was extracted from whole blood, and reverse
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Table 1 Review genomic and clinical information on patients with duplication involving GRB10
Patient/source Our patient Patients TB/LB from
Joyce et al. [13]
Patient DP from Monk
et al. [17]
Patients HC/AC from
Monk et al. [16]
Patient from Eggermann
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transcription was performed using a commercial kit
(Promega, USA). A blood sample from the proband’s
mother was used as the control. The primer sequences
that were used and their descriptions are included in
Additional file 1: Table S2.
Measurement of IGF1 and IGFBP3
We measured the levels of IGF1 and IGF binding
protein-3 (IGFBP3) in the patient’s serum using enzyme-
linked immunosorbent assay (ELISA) kits (Diagnostic
Systems Laboratories, Webster, TX, USA) according to
the manufacturer’s instructions.
Sequencing of the fibroblast growth factor receptor-3
gene (FGFR3)
DNA samples were tested for common disease-associated
mutations in FGFR3 (achondroplasia and hypochondro-
plasia: p.Gly380Arg and p.Asn540Lys, respectively; thana-
tophoric dysplasia type I: p.Arg248Cys, p.Tyr373Cys,
p.Ser249Cys, and p.X807; and thanatophoric dysplasia
type II: p.Lys650Glu) using Sanger sequencing. The
primer sequences are shown in Additional file 1: Table S3
(reference sequence for the FGFR3 gene: NM_000142.4).
Sanger sequencing was performed according to the manu-
facturer’s instructions using a Big Dye Terminator Cycle
Sequencing Kit (version 3.1) and analyzed using an ABI
Prism 3130xl Genetic DNA analyzer.
Results
Karyotyping analysis of the patient revealed a normal 46,
XY karyotype. CMA revealed a 574 kb duplication at
7p12.1 (arr[hg19] 7p12.1(50,654,827- 51,229,221) × 3dn)
(Fig. 4). This duplication was not detected in either the
patient’s parents or siblings, indicating that it was a de
novo duplication. We used Chromosome Analysis Suite
software (NetAffx 33.1, Affymetrix, USA) to analyze the
family trio SNP-array data, and we found that the dupli-
cation originated from the mother. The duplication was
further confirmed using RT-PCR analysis. The GRB10
expression level in the patient’s blood was three-fold
higher than the level in his mother’s blood (Fig. 5a). The
levels of IGF1 and IGFBP3 in the patient were <25.0 ng/ml
Fig. 1 Clinical features of the proband at 2 years of age. a Note the prominent forehead, triangular face, downward-slanting mouth and micrognathia.
The proband also presented with very short limbs and body asymmetry, b a low nasal bridge, and c trident hands and fifth finger clinodactyly, d scoliosis
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and 1.78 ng/ml, respectively, which was far below normal
levels. Sequencing of the FGFR3 gene identified a FGFR3
c.1138 G >A (p.Gly380Arg) mutation (Fig. 5b).
Discussion
The patient exhibited features such as scoliosis and a
trident configuration of the hands all of which can be
explained by a mutations in FGFR3 at c.1138 G >
A(p.Gly380Arg). However, the speech delay, hypotonia
and small triangular face phenotypes were not commonly
reported in previous cases of ACH (Table 2) [9, 12]. A hy-
poplastic corpus callosum and hydrocephalus could po-
tentially be CNS manifestations of non-treated/severe
achondroplasia. In addition, the observation of a global
developmental delay could not be definitively separated
from the consequences of the identified FGFR3 mutation.
Fig. 3 Brain MRI images showed a hypoplastic corpus callosum, enlargement of the lateral ventricles and hydrocephalus (a and b)
Fig. 2 Spine X-ray images showed mild kyphosis (a) and scoliosis (b) at the thoracic and lumbar region. Bone age is delayed (c)
Yuan et al. Orphanet Journal of Rare Diseases  (2016) 11:89 Page 5 of 9
Finally, at birth, patients with achondroplasia present with
a relatively short stature that does not affect weight,
whereas this patient had a low weight at birth. In addition,
no overt body asymmetry was reported in this patient. Ac-
cordingly, the one unique feature of this patient that can
be directly linked to a GRB10 duplication is the prenatal
onset growth delay.
In our patient, we detected a three-fold increase in
GRB10 expression. GRB10 is an imprinted gene on
7p12.1. Because it is a key genetic component of devel-
opmental programming, recent studies have also sug-
gested that placental GRB10 plays a role in regulating
fetoplacental growth and that it is thereby implicated in
the pathophysiology of fetal growth restriction in the
context of fetal gender [2, 26]. Studies have consistently
supported the notion that increases in gene dosage are
the main contributors to the over-production of the
GRB10 gene product. The GRB10 gene encodes an
Fig. 4 Overview of previously described cases shown to have genomic imbalances at 7p12.1 that involved GRB10. (Blue: duplications). Red vertical
lines demarcate the genomic interval of the GRB10 gene (a). Scatter plot of a Cytoscan HD array at 7p12.1 showing a duplication interval
involving the whole GRB10 gene and part of the COBL gene (b)
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adaptor protein that interacts with IGF1 and insulin re-
ceptors to negatively regulate the IGF1 growth cascade
[5, 18]. A previous study reported that endogenous
GRB10 expression was increased in the hippocampus of
rats with diabetic encephalopathy and that this increase
might result in damaged nerve functions and cognitive
impairments. In addition, the insulin/IGF1 signaling
pathways have been implicated in dysregulated synaptic
maturation and may play key roles in brain aging and
dementia as well as learning and cognitive functions in
rodent models [14, 19]. In the present study, the IGF1
and IGFBP3 levels in the patient were far below normal
levels, consistent with a model in which the duplication
of GRB10 directly inhibits the phosphorylation of the
IGF1R substrate and reduces the level of Grb10 expres-
sion to below normal limits, which may result in ner-
vous system impairments such as growth delays and
intellectual disabilities (ID) [23]. These findings suggest
Fig. 5 a GRB10 expression levels were analyzed in blood samples using RT-PCR. b DNA sequences corresponding to the patient’s FGFR genes.
A FGFR3 c.1138 G > A (p.Gly380Arg) mutation was found
Table 2 Comparison of clinical abnormalities with Achondroplasia (ACH) and Silver-Russell syndrome (SRS)
Clinical abnormalities Achondroplasia (ACH) Silver-Russell syndrome (SRS) Our patient
Prenatal IUGR - + +
Special face
macrocephaly - + +
broad foreheads + - +
pointed - + +
triangular shaped - + +
nose bridge collapse + - +
small chins - + +
Hand
a trident configuration of the hands + - +
fifth finger clinodactyly - + +
Body
asymmetry of limbs - + +
vertebrae scoliosis thoracic kyphosis Scoliosis and thoracic kyphosis
Hypotonia - + +
Developmental delay - + +
Delayed speech - + +
Intellectual disability - + +
Feeding difficulties in early childhood - + +
Snoring (coarse breath sounds) + - +
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that the duplication of GRB10 contributes to the pre-
natal onset growth delay phenotype that was observed in
our patient and may also explain the ID features in SRS.
Previous studies of mice with uniparental disomy of
Grb10 demonstrated that Grb10 is a typical imprinted
gene and that it affects growth mainly via an imprinting
mechanism [1, 20, 21, 25]. However, the imprinting be-
havior of human GRB10, which is located on chromo-
some 7, has been shown to be different from that of its
mouse homolog [11]. Human GRB10 is biallelically
expressed in most tissues, with the exception of the pla-
cental villus trophoblast and fetal brain tissues [10, 15].
Because of the known complexity of the 7p12.1 imprint-
ing regions and their interactions, interpretations of
copy number variations in this region are complicated.
The clinical outcomes in cases of micro-duplications are
influenced by the size, breakpoint positions and parental
inheritance of the imbalance and by the imprinting sta-
tus of the affected genes.
Though, the duplication that was identified in our pro-
positus could potentially have disrupted the genomic
structure of the cordon-bleu WH2 repeat protein
(COBL) gene, which is specifically expressed in the node
and its derivatives until organogenesis, we could not
exclude the possibility that a disruption in COBL might
have been involved in the patient’s phenotype. In
addition, there are no known correlations between
mutations in FGFR3 and the duplication of GRB10.
Conclusion
The data related to the patient described in the present
study at least suggest that mutations in FGFR3 cause
ACH but do not influence the effects of the duplication
of GRB10 on prenatal onset growth delay in SRS. The
results of our study also suggest that phenotypes are
rarely “simple” or directly related to specific gene defects
and that combinations of uncommon, rare and excep-
tional molecular defects, which can be explored and
used in diagnoses, may explain the so-called variability
observed in the expression of dominant traits.
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